GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Other Stockholders Equity

PixarBio (PixarBio) Other Stockholders Equity : $0.00 Mil (As of Sep. 2016)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio Other Stockholders Equity?

PixarBio's Other Stockholders Equity for the quarter that ended in Sep. 2016 was $0.00 Mil.

PixarBio's quarterly Other Stockholders Equity stayed the same from Mar. 2016 ($0.00 Mil) to Jun. 2016 ($0.00 Mil) but then increased from Jun. 2016 ($0.00 Mil) to Sep. 2016 ($0.00 Mil).

PixarBio's annual Other Stockholders Equity increased from . 20 ($0.00 Mil) to Dec. 2014 ($-0.00 Mil) but then stayed the same from Dec. 2014 ($-0.00 Mil) to Dec. 2015 ($-0.00 Mil).


PixarBio Other Stockholders Equity Historical Data

The historical data trend for PixarBio's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Other Stockholders Equity Chart

PixarBio Annual Data
Trend Dec14 Dec15
Other Stockholders Equity
- -

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PixarBio Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


PixarBio Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PixarBio's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines